# Efficacy and Safety of 14-day Concomitant Therapy for Helicobacter Pylori Infection

> **NCT04991584** · NA · UNKNOWN · sponsor: **Shandong University** · enrollment: 60 (estimated)

## Conditions studied

- Helicobacter Pylori Infection

## Interventions

- **DRUG:** Amoxicillin,Tetracycline,Furazolidone,Levofloxacin,Vonoprazan fumarate, Esomeprazole ,

## Key facts

- **NCT ID:** NCT04991584
- **Lead sponsor:** Shandong University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-08-04
- **Primary completion:** 2022-06-30
- **Final completion:** 2022-07-01
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2021-08-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04991584

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04991584, "Efficacy and Safety of 14-day Concomitant Therapy for Helicobacter Pylori Infection". Retrieved via AI Analytics 2026-07-24 from https://api.ai-analytics.org/clinical/NCT04991584. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*